Leukemia Treatment Derived From Cord Blood Gains FDA Approval for Clinical Trials
A CAR-T cell therapy for acute lymphoblastic leukemia[1] has recently been approved by the FDA for use in clinical trials in the United States. The therapy is based on cells derived from allogeneic (donor) umbilical cord blood; it is the very first such treatment to...
Toddler’s Rare Leukemia Treated by Sister’s Cord Blood
After two planned transplants from unrelated donors fell through at the very last minute, Australian three-year-old Tommy Bacon is now in remission from a rare, dangerous form of leukemia following a transplant of the stem cells from his baby sister’s cord blood.[1]...
Gene Editing Stem Cell Therapy for Blood Disorder Begins NHS Rollout
Last week it was announced that a new gene editing stem cell therapy for beta thalassemia would start to be made available on the UK’s National Health Service. The therapy, called Casgevy, is developed by Vertex Pharmaceuticals and CRISPR Therapeutics and...
World Sickle Cell Day and the Benefits of Cord Blood Banking
This year’s World Sickle Cell Day is on the 19th June, a day to recognize and raise awareness of the disease, the millions around the world who suffer from it, and ongoing research into how treatment is advancing. With this year’s theme being ‘we are STRONGER...
